Skip to main content

Antifreeze Proteins Market Future Business Opportunities 2023-2028

 


Global Antifreeze Protein Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020.

For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 172 million cases and 3.7 million deaths due to coronavirus (COVID-19) were reported till June 06, 2021, across the globe.

Impact of COVID-19 on Demand and Supply of Antifreeze Proteins

The COVID-19 pandemic and lockdown in various countries across the globe have negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has negatively impacted the entire supply chain of the pharmaceutical industry, food & beverage industry, cosmetics industry, and others mainly due to strict lockdown in several regions. However, the demand for antifreeze proteins is increasing in this COVID-19 pandemic due to a growing need of development of new vaccine candidates for treatment of coronavirus cases. For instance, according to the Business Standard Report 2020, there is an increased pressure on the governments all around the world to ensure proper storage and transport facilities for distribution of newly approved COVID-19 vaccines. For instance, according to the Centers for Disease Control and Prevention (CDC), Pfizer vaccine need to be stored at a very low temperature of about -70 degree Celsius. Antifreeze proteins are used to maintain the structural stability of vaccines stored under subzero temperature conditions.

Thus, impact of the coronavirus (COVID-19) pandemic is expected to boost growth of the global antifreeze proteins market during the forecast period, owing to the increased demand of antifreeze proteins for storage of COVID-19 vaccines.

The increasing product launches and approvals are the major factors that are expected to drive the market growth over the forecast period

The increasing launches of products and approvals are expected to drive growth of the global antifreeze proteins market over the forecast period. For instance, in May 2021, AquaBounty Technologies, a U.S. biotechnology company launched genetically engineered salmon, which is the first of its kind in the world and also the only one to be currently available for commercial harvest. This newly developed genetic modification technology will enable the company to produce 70% more salmon than the traditional methods of spawning and breeding. A boost in product launches in the field of frozen fish is expected to boost the antifreeze protein market as these proteins are widely used as a preservative for storage of frozen fish.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more